Recently, an rRNA-based polymerase chain reaction (PCR) Microbiol. 58:2606Microbiol. 58: -2615Microbiol. 58: , 1992. In this study, the diagnostic value of this PCR assay for the detection of Mycoplasma pulmonis in infected rats was studied. For this purpose, 25 Wistar rats were infected intranasally with M. pulmonis strain M72-138 and investigated for the presence of this pathogen by both in vitro isolation and PCR. Five rats were monitored longitudinally by screening of throat swabs at several time points for up to 248 days postinfection. The remaining 20 rats were killed between 3 and 87 days postinfection, and organism recovery from both throat and urogenital tract specimens was attempted. M. pulmonis could be detected in the throat for up to 248 days postinfection but not in the urogenital tract, either by culture or by PCR. PCR proved to be the optimal method for testing throat samples. All samples in which M. pulmonis was detected by culture were also positive by PCR. By PCR, M. pulmonis was also detected in 3.7% of the samples which were culture negative and in 9.9%o of the samples from which cultures were overgrown with bacteria. The results of this study demonstrate the suitability of PCR for the detection of mycoplasmal infection in rodents.
Mycoplasmal infections may cause severe problems in laboratory rodent colonies. Recent surveys indicate that about 60% of barrier-maintained and nearly all conventionally housed laboratory rat and mouse colonies are infected with one or more mycoplasmas (8, 10) . The mycoplasmal species isolated from rats and mice (Mycoplasma pulmonis, M. arthritidis, M. neurolyticum, M. muris, and M. collis) have been associated with several disease manifestations.
One of the main diseases is murine respiratory mycoplasmosis, or chronic respiratory disease, which is caused by M. pulmonis and involves the nasal passages, middle ears, trachea, and lungs, causing rhinitis, otitis media, tracheitis, and pneumonia (5, 11) . Besides respiratory disease, this organism can also produce genital infections, resulting in reduced birth rates (1, 5, 6) . However, in spite of their pathogenic potential, mycoplasmal infections can remain inapparent. These inapparent infections may be very treacherous because mycoplasmas possess immunomodulatory activities which can influence the outcome of experiments (4, 5) .
A first step in building and maintaining a mycoplasma-free colony is the use of an efficient detection system to routinely identify mycoplasma carriers (3). The methods currently used for the diagnosis of mycoplasmal infections show several shortcomings. In vitro isolation, which requires multisite culture for reliable results (3), is laborious and time-consuming and lacks sensitivity for several species, while serological methods are often hampered by crossreactions between different species (3, 4, 12) . In addition, it has also been shown that animals can be infected and remain seronegative for weeks after infection (2) .
Recently, we developed a polymerase chain reaction (PCR) assay for the detection of mycoplasmas at both the * Corresponding author. species and genus level (13) . Primers selected from the variable 16S rRNA regions of the five murine mycoplasmal species were all species specific in this PCR assay. With a high copy number of rRNA (104 copies per cell), a highly sensitive assay was established in which the nucleic acid content equivalent to a single microorganism could be detected (13) .
In this study, the suitability of this PCR assay for the detection of mycoplasmal infection was tested in Wistar rats that were experimentally infected with M. pulmonis. We compared culture and the PCR assay for the detection of M. pulmonis in throat and urogenital tract samples collected at several times postinfection.
MATERUILS AND METHODS
Animals. Twenty-nine germ-free Cpb:WU (Wistar) rats, male and female, aged 10 weeks, were used. These rats are proven to be serologically negative for M. pulmonis. The rats were kept in sterile isolators and fed sterilized rat-mice food. Room temperature and humidity were regulated (21 + 2°C, 60% + 10% relative humidity). The rats were housed in Macrolon cages, three animals per cage, with softwood granules as bedding. Noninfected control rats were housed separately from the experimentally infected rats.
Media. For cultivation in liquid and agar media, a modification of the medium described by Chanock et al. (7) PCR analysis. Samples (1 ml) obtained from the throat and urogenital swabs were centrifuged for 10 min at 10,000 x g. RNA was extracted by the RNAzol B method (Cinna Biotecx) according to the manufacturer's instructions. cDNA synthesis of the RNA, the PCR assay, analysis of the amplified samples by electrophoresis, and subsequent hybridization were performed as described previously (13) . PCR was performed with M. pulmonis species-specific primers (sense primer, 5'-AGCGllTrGC1TCACF''lTGAA-3'; antisense primer, 5'-GGGCAT1TCCTCCCTAAGCT-3'), which generate a 266-bp amplification product. The thermal profile involved 40 cycles of denaturation at 94°C for 1 min, primer annealing at 550C for 1 min, and primer extension at 720C for 2 min. Hybridization was performed with the internal 32P-end-labeled oligonucleotide GPO-1 (5'-ACTCCT ACGGGAGGCAGCAGTA-3').
Culture. The suspended throat and urogenital swab samples were incubated at 370C until the color of the medium changed to orange-red. Cultures were incubated for 6 weeks before being considered negative.
Positive cultures were identified as M. pulmonis by PCR, since we had previously demonstrated (unpublished data) a 100% correlation between identification of the organisms grown in culture medium by the growth inhibition test and identification by PCR with species-specific primers. For this PCR, DNA was extracted from the organisms grown in culture medium, and rDNA sequences were amplified as described previously (13) , with the M. pulmonis-specific primers described above. M. pulmonis was not demonstrated in any of the cultures which did not display a change of color. ELISA. Routine enzyme-linked immunosorbent assays (ELISAs) for immunoglobulin G antibodies to M. pulmonis were performed as described by Cassell et al. (3), with serum samples collected from rats 1 through 5 at the first 10 time points and from rats 6 through 29 on the day of death.
RESULTS
Culture and PCR analysis were compared for the detection of M. pulmonis in the throat and urogenital tract of 25 experimentally infected Wistar rats. Infection of these rats was confirmed by ELISA for the detection of immunoglobulin G antibodies against M. pulmonis (data not shown).
Rats 1 through 5 were investigated longitudinally for the presence of M. pulmonis in the throat at several time points between 3 and 248 days postinfection. Table 1 demonstrates that with the PCR assay, which includes Southern blot analysis, M. pulmonis was detected in the throat of rats 1, 2, 4, and 5 at all time points investigated, while culture failed to detect M. pulmonis in two samples (throat swabs from rats 1 and 2 collected 248 days postinfection). The failure to detect M. pulmonis in the throat of rat 1 at day 151 postinfection by both PCR and culture is probably the result of an error in collecting the sample, since subsequent samples were again positive for M. pulmonis. Remarkably, M. pulmonis was no longer detected in the throat of rat 3 from day 42 postinfection. b Bacterial overgrowth was observed in four cases. Figure 1 shows an example of an electrophoretic analysis of the PCR products. Besides the 266-bp fragment, a smaller fragment (about 175 bp) was amplified in the RNA PCR which was not found in the DNA PCR. This 175-bp fragment also hybridized with the internal probe (data not shown). The origin of this smaller product is unknown. The addition of Perfect Match Enhancer (Stratagene), which destabilizes mismatched primer-template complexes, or dactinomycin, which reduces secondary RNA structures, did not prevent the amplification of this smaller product (data not shown).
DISCUSSION
In this study, the suitability of the 16S rRNA-based mycoplasmal PCR assay (13) as a tool for the diagnosis of mycoplasmal infection was examined in Wistar rats experimentally infected with M. pulmonis. In a preliminary study (data not shown), we had found that M. pulmonis could be detected in throat swab samples of experimentally infected rats by PCR analysis. It was also found that the sensitivity was increased when the rRNA instead of the rDNA target was used, since the rDNA PCR failed to detect M. pulmonis in some samples which were positive in the rRNA PCR. Therefore, in the current study, the rRNA PCR was performed for the detection of M. pulmonis.
Throat 
